Spinal cord atrophy in multiple sclerosis caused by white matter volume loss

Archives of Neurology

Volumn 62, Issue 12, 2005, Pages 1859-1862

  Gilmore, Christopher P ^a,f   DeLuca, Gabriele C ^b   Bö, Lars ^d,e   Owens, Trudy ^a   Lowe, James ^a   Esiri, Margaret M ^b,c   Evangelou, Nikos ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Oxford Radcliffe National Health Service Trust   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL CORD; SPINAL CORD ATROPHY; WHITE MATTER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATROPHY; AUTOPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; NEURAL PATHWAYS; NEURONS; REPRODUCIBILITY OF RESULTS; SEX FACTORS; SILVER STAINING; SPINAL CORD; SPINAL CORD DISEASES;

EID: 28944442268     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.62.12.1859     Document Type: Article

References (13)

1. Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif ) treatment trial. J Neurol Neurosurg Psychiatry. 2003;74:1090-1094.
2. Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol. 2002;52:650-653.
3. Sailer M, Fischl B, Salat D, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain. 2003;126:1734-1744.
4. DeLuca GC, Ebers GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain. 2004;127:1009-1018.
5. Evangelou N, DeLuca GC, Owens T, Esiri MM. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain. 2005;128:29-34.
6. Lowe J, Cox G. Neuropathological techniques. In: Bancroft JD, Stevens A, eds. Theory and Practice of Histological Techniques. Edinburgh, Scotland: Churchill Livingstone; 1990:348, 349, 356.
7. Highley JR, Esiri MM, McDonald B, et al. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain. 1999;122:99-110.
8. Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol. 1978;4:151-162.
9. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol. 2000;48:893-901.
10. Chard DT, Griffin CM, McLean MA, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain. 2002;125:2342-2352.
11. Evangelou N, Konz D, Esiri MM, et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 2001;124:1813-1820.
12. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003;62:723-732.
13. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001;50:389-400.